An Italian database for MEN1 patients
Part of Cancer, Genetic & congenital, Hormones & metabolism clinical trials.
This trial is building a database to better understand Multiple Endocrine Neoplasia Type 1 (MEN1). If you have been diagnosed with MEN1, you may be eligible to help researchers learn more about the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of MEN1 syndrome (confirmed by genetic testing, clinical criteria, or family history).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This study is a registry that collects information from people newly diagnosed with myelodysplastic syndrome (MDS). It helps researchers understand the condition better and may guide future studies.
This study is creating a database of people with hypoparathyroidism or pseudohypoparathyroidism in Italy. It may help researchers learn more about these conditions and improve future care.
This study follows people with Multiple Endocrine Neoplasia type 1 (MEN1) over time, including those with symptoms, certain isolated hormone gland problems, and people without symptoms who have the MEN1 gene change. It may help doctors learn how MEN1 starts and progresses so care can be better timed and personalized.
This study follows people who have Multiple Endocrine Neoplasia type 1 (MEN1), a genetic condition that can cause tumors in hormone glands. It aims to monitor symptoms and lesions over time to better understand how the condition progresses and how to manage it.
This study looks at blood chemistry (metabolomics) and genetic information in people who have MEN1, especially if they are being evaluated for pancreatic neuroendocrine tumors. It may help doctors better diagnose these tumors by finding patterns in test results.
Hear when a new Multiple Endocrine Neoplasia Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.